Microenvironmental reorganization in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 Apr 2024
Historique:
received: 30 01 2023
accepted: 22 03 2024
medline: 16 4 2024
pubmed: 16 4 2024
entrez: 15 4 2024
Statut: epublish

Résumé

The tumor microenvironment plays a crucial role in determining response to treatment. This involves a series of interconnected changes in the cellular landscape, spatial organization, and extracellular matrix composition. However, assessing these alterations simultaneously is challenging from a spatial perspective, due to the limitations of current high-dimensional imaging techniques and the extent of intratumoral heterogeneity over large lesion areas. In this study, we introduce a spatial proteomic workflow termed Hyperplexed Immunofluorescence Imaging (HIFI) that overcomes these limitations. HIFI allows for the simultaneous analysis of > 45 markers in fragile tissue sections at high magnification, using a cost-effective high-throughput workflow. We integrate HIFI with machine learning feature detection, graph-based network analysis, and cluster-based neighborhood analysis to analyze the microenvironment response to radiation therapy in a preclinical model of glioblastoma, and compare this response to a mouse model of breast-to-brain metastasis. Here we show that glioblastomas undergo extensive spatial reorganization of immune cell populations and structural architecture in response to treatment, while brain metastases show no comparable reorganization. Our integrated spatial analyses reveal highly divergent responses to radiation therapy between brain tumor models, despite equivalent radiotherapy benefit.

Identifiants

pubmed: 38622132
doi: 10.1038/s41467-024-47185-9
pii: 10.1038/s41467-024-47185-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3226

Investigateurs

Johanna A Joyce (JA)
Spencer S Watson (SS)
Tristan Whitmarsh (T)
Bernd Bodenmiller (B)

Informations de copyright

© 2024. The Author(s).

Références

Grech, N. et al. Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population. Cureus 12, e8195 (2020).
pubmed: 32572354 pmcid: 7302718
Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).
pubmed: 15758009 doi: 10.1056/NEJMoa043330
Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459–466 (2009).
pubmed: 19269895 doi: 10.1016/S1470-2045(09)70025-7
Akkari, L. et al. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Sci. Transl. Med. 12 https://doi.org/10.1126/scitranslmed.aaw7843 (2020).
Croci, D. et al. Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages. Sci. Transl. Med. 14, eabo2952 (2022).
pubmed: 36260692 doi: 10.1126/scitranslmed.abo2952
Quail, D. F. et al. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science 352, aad3018 (2016).
pubmed: 27199435 pmcid: 5450629 doi: 10.1126/science.aad3018
Zomer, A., Croci, D., Kowal, J., van Gurp, L. & Joyce, J. A. Multimodal imaging of the dynamic brain tumor microenvironment during glioblastoma progression and in response to treatment. iScience 25, 104570 (2022).
pubmed: 35769877 pmcid: 9234718 doi: 10.1016/j.isci.2022.104570
Alexander, J. et al. Multimodal single-cell analysis reveals distinct radioresistant stem-like and progenitor cell populations in murine glioma. Glia 68, 2486–2502 (2020).
pubmed: 32621641 pmcid: 7586969 doi: 10.1002/glia.23866
Berg, T. J. et al. The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2. Cancer Res. 81, 2101–2115 (2021).
pubmed: 33483373 doi: 10.1158/0008-5472.CAN-20-1785
Kievit, F. M. et al. Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma. Nanomedicine 13, 2131–2139 (2017).
pubmed: 28614736 doi: 10.1016/j.nano.2017.06.004
Ali, M. Y. et al. Radioresistance in Glioblastoma and the Development of Radiosensitizers. Cancers 12, 2511 (2020).
pubmed: 32899427 pmcid: 7564557 doi: 10.3390/cancers12092511
Gimple, R. C., Yang, K., Halbert, M. E., Agnihotri, S. & Rich, J. N. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat. Rev. Cancer 22, 497–514 (2022).
pubmed: 35710946 doi: 10.1038/s41568-022-00486-x
Squatrito, M. & Holland, E. C. DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance. Cancer Res. 71, 5945–5949 (2011).
pubmed: 21917735 doi: 10.1158/0008-5472.CAN-11-1245
Beach, C., MacLean, D., Majorova, D., Arnold, J. N. & Olcina, M. M. The effects of radiation therapy on the macrophage response in cancer. Front. Oncol. 12, 1020606 (2022).
pubmed: 36249052 pmcid: 9559862 doi: 10.3389/fonc.2022.1020606
McLaughlin, M. et al. Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat. Rev. Cancer 20, 203–217 (2020).
pubmed: 32161398 doi: 10.1038/s41568-020-0246-1
Barker, H. E., Paget, J. T., Khan, A. A. & Harrington, K. J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer 15, 409–425 (2015).
pubmed: 26105538 pmcid: 4896389 doi: 10.1038/nrc3958
Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417–422 (2014).
pubmed: 24584193 doi: 10.1038/nmeth.2869
Lin, J. R. et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. Elife 7 https://doi.org/10.7554/eLife.31657 (2018).
Keren, L. et al. MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure. Sci. Adv. 5, eaax5851 (2019).
pubmed: 31633026 pmcid: 6785247 doi: 10.1126/sciadv.aax5851
Norris, J. L. & Caprioli, R. M. Imaging mass spectrometry: a new tool for pathology in a molecular age. Proteom. Clin. Appl. 7, 733–738 (2013).
doi: 10.1002/prca.201300055
Kennedy-Darling, J. et al. Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction. Eur. J. Immunol. 51, 1262–1277 (2021).
pubmed: 33548142 pmcid: 8251877 doi: 10.1002/eji.202048891
Bai, Z., Su, G. & Fan, R. Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery. Genom. Proteom. Bioinforma. 19, 191–207 (2021).
doi: 10.1016/j.gpb.2021.02.004
Lewis, S. M. et al. Spatial omics and multiplexed imaging to explore cancer biology. Nat. Methods 18, 997–1012 (2021).
pubmed: 34341583 doi: 10.1038/s41592-021-01203-6
Good, C. J. et al. High Spatial Resolution MALDI Imaging Mass Spectrometry of Fresh-Frozen Bone. Anal. Chem. 94, 3165–3172 (2022).
pubmed: 35138834 pmcid: 9741954 doi: 10.1021/acs.analchem.1c04604
Gendusa, R., Scalia, C. R., Buscone, S. & Cattoretti, G. Elution of High-affinity (>10-9 KD) Antibodies from Tissue Sections: Clues to the Molecular Mechanism and Use in Sequential Immunostaining. J. Histochem. Cytochem. 62, 519–531 (2014).
pubmed: 24794148 pmcid: 4174624 doi: 10.1369/0022155414536732
Gut, G., Herrmann, M. D. & Pelkmans, L. Multiplexed protein maps link subcellular organization to cellular states. Science 361 https://doi.org/10.1126/science.aar7042 (2018).
Hambardzumyan, D., Amankulor, N. M., Helmy, K. Y., Becher, O. J. & Holland, E. C. Modeling Adult Gliomas Using RCAS/t-va Technology. Transl. Oncol. 2, 89–95 (2009).
pubmed: 19412424 pmcid: 2670576 doi: 10.1593/tlo.09100
Ozawa, T. et al. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell 26, 288–300 (2014).
pubmed: 25117714 pmcid: 4143139 doi: 10.1016/j.ccr.2014.06.005
Klemm, F. et al. Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis. Nat. Cancer 2, 1086–1101 (2021).
pubmed: 35121879 doi: 10.1038/s43018-021-00254-0
Bowman, R. L. et al. Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies. Cell Rep. 17, 2445–2459 (2016).
pubmed: 27840052 pmcid: 5450644 doi: 10.1016/j.celrep.2016.10.052
Thevenaz, P., Ruttimann, U. E. & Unser, M. A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Process 7, 27–41 (1998).
pubmed: 18267377 doi: 10.1109/83.650848
Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
pubmed: 29203879 pmcid: 5715110 doi: 10.1038/s41598-017-17204-5
Schmidt, U., Weigert, M., Broaddus, C. & Myers, G. Cell Detection with Star-Convex Polygons; Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) (Springer International Publishing, 2018).
Ronneberger, O., Fischer, P. & Brox, T. U-Net: Convolutional Networks for Biomedical Image Segmentation. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. Lecture Notes in Computer Science, (Springer, Cham, 2015).
Van Gassen, S. et al. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636–645 (2015).
doi: 10.1002/cyto.a.22625
Fomchenko, E. I. et al. Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression. PLoS One 6, e20605 (2011).
pubmed: 21754979 pmcid: 3130733 doi: 10.1371/journal.pone.0020605
Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006).
pubmed: 17051156 doi: 10.1038/nature05236
Schurch, C. M. et al. Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front. Cell 182, 1341–1359.e1319 (2020).
pubmed: 32763154 pmcid: 7479520 doi: 10.1016/j.cell.2020.07.005
Windhager, J., Bodenmiller, B. & Eling, N. An end-to-end workflow for multiplexed image processing and analysis. bioRxiv https://doi.org/10.1101/2021.11.12.468357 (2021).
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. URL https://www.R-project.org/ (2021).
Schapiro, D. et al. histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat. Methods 14, 873–876 (2017).
pubmed: 28783155 pmcid: 5617107 doi: 10.1038/nmeth.4391
Kinkhabwala, A. et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci. Rep. 12, 1911 (2022).
pubmed: 35115587 pmcid: 8813936 doi: 10.1038/s41598-022-05841-4
Di Martino, J. S. et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat. Cancer 3, 90–107 (2022).
pubmed: 35121989 doi: 10.1038/s43018-021-00291-9
Hoogstrate, Y. et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell 41, 678–692 e677 (2023).
pubmed: 36898379 doi: 10.1016/j.ccell.2023.02.019
Pyonteck, S. M. et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19, 1264–1272 (2013).
pubmed: 24056773 pmcid: 3840724 doi: 10.1038/nm.3337
Dai, C. et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15, 1913–1925 (2001).
pubmed: 11485986 pmcid: 312748 doi: 10.1101/gad.903001
Tchougounova, E. et al. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene 26, 6289–6296 (2007).
pubmed: 17438529 doi: 10.1038/sj.onc.1210455
Ljosa, V., Sokolnicki, K. L. & Carpenter, A. E. Annotated high-throughput microscopy image sets for validation. Nat. Methods 9, 637 (2012).
pubmed: 22743765 pmcid: 3627348 doi: 10.1038/nmeth.2083
Caicedo, J. C. et al. Nucleus segmentation across imaging experiments: the 2018 Data Science Bowl. Nat. Methods 16, 1247–1253 (2019).
pubmed: 31636459 pmcid: 6919559 doi: 10.1038/s41592-019-0612-7
Caicedo, J. C. et al. Evaluation of Deep Learning Strategies for Nucleus Segmentation in Fluorescence Images. Cytom. A 95, 952–965 (2019).
doi: 10.1002/cyto.a.23863
Coelho, L. P., Shariff, A. & Murphy, R. F. Nuclear Segmentation in Microscope Cell Images: A Hand-Segmented Dataset and Comparison of Algorithms. Proc. IEEE Int Symp. Biomed. Imaging 5193098, 518–521 (2009).
pubmed: 20628545 pmcid: 2901896
Csardi, G. & Nepusz, T. The igraph software package for complex network research. InterJ. Complex Syst. 1695, 1–9 (2006).

Auteurs

Spencer S Watson (SS)

Department of Oncology, University of Lausanne, Lausanne, Switzerland. drspencerwatson@gmail.com.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. drspencerwatson@gmail.com.
Agora Cancer Research Center, Lausanne, 1011, Switzerland. drspencerwatson@gmail.com.
L. Lundin and Family Brain Tumor Research Center, Departments of Oncology and Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland. drspencerwatson@gmail.com.

Benoit Duc (B)

Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
Agora Cancer Research Center, Lausanne, 1011, Switzerland.
L. Lundin and Family Brain Tumor Research Center, Departments of Oncology and Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland.

Ziqi Kang (Z)

Department of Cellular and Molecular Biology, Karolinska Institutet and SciLifeLab, Stockholm, Sweden.

Axel de Tonnac (A)

Department of Cellular and Molecular Biology, Karolinska Institutet and SciLifeLab, Stockholm, Sweden.

Nils Eling (N)

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.

Laure Font (L)

Department of Oncology, University of Lausanne, Lausanne, Switzerland.
École Polytechnique Fédérale Lausanne, Lausanne, Switzerland.

Tristan Whitmarsh (T)

Machine Intelligence Laboratory, Department of Engineering, University of Cambridge, Cambridge, UK.

Matteo Massara (M)

Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
Agora Cancer Research Center, Lausanne, 1011, Switzerland.
L. Lundin and Family Brain Tumor Research Center, Departments of Oncology and Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland.

Bernd Bodenmiller (B)

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.

Jean Hausser (J)

Department of Cellular and Molecular Biology, Karolinska Institutet and SciLifeLab, Stockholm, Sweden.

Johanna A Joyce (JA)

Department of Oncology, University of Lausanne, Lausanne, Switzerland. johanna.joyce@unil.ch.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. johanna.joyce@unil.ch.
Agora Cancer Research Center, Lausanne, 1011, Switzerland. johanna.joyce@unil.ch.
L. Lundin and Family Brain Tumor Research Center, Departments of Oncology and Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland. johanna.joyce@unil.ch.
Cancer Research UK, Cancer Grand Challenges iMAXT Consortium, University of Cambridge, Cambridge, UK. johanna.joyce@unil.ch.

Classifications MeSH